恶性淋巴瘤的规范治疗PPT课件.ppt

* Actuarial survival curves for patients with indolent NHL treated at Stanford University from 1960 to 1976, 1976 to 1987, and 1987 to 1996 are essentially indistinguishable, which shows that the widespread use of single-agent or multiagent chemotherapy or combined modality therapy has not had a significant impact on the natural course of the disease.54 （斯坦福大学回顾了1960－1975，1976－1986，1987－1996年惰性淋巴瘤的生存曲线，显示无论采用何种治疗均没有明显改变该疾病的自然病程，中位生存为11年） * 98年随着美罗华问世后，FL患者的OS有了显著改善 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * - * k * * FLYER 研究目的在于：在预后非常好的亚组中研究CHOP化疗疗程能否进一步减少？ 既往在这部分患者中多采用C